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Abstract
Background—Approximately 15% of HIV-infected MSM engaged in HIV primary care have 
been diagnosed with an STI in the past year, yet STI testing frequency remains low.
Methods—We sought to quantify STI testing frequencies at a large, urban HIV care clinic, and 
to identify patient- and provider-related barriers to increased STI testing. We extracted laboratory 
data in aggregate from the electronic medical record to calculate STI testing frequencies (defined 
as the number of HIV-infected MSM engaged in care who were tested at least once over an 18-
month period divided by the number of MSM engaged in care). We created anonymous surveys of 
patients and providers to elicit barriers.
Results—Extra-genital gonorrhea and chlamydia testing were low (29%–32%), but the 
frequency of syphilis testing was higher (72%). Patients frequently reported high-risk behaviors, 
including drug use (16.4%) and recent bacterial STI (25.5%), as well as substantial rates of recent 
testing (>60% in prior 6 months). Most (72%) reported testing for STI in HIV primary care, but 
one-third went elsewhere for “easier” (42%), anonymous (21%) or more frequent (16%) testing. 
HIV primary care providers lacked testing and treatment knowledge (25–32%), and cited lack of 
time (68%), discomfort with sexual history taking and genital exam (21%), and patient reluctance 
(39%) as barriers to increased STI testing.
Conclusion—STI testing in HIV care remains unacceptably low. Enhanced education of 
providers, along with strategies to decrease provider time and increase patient ease and frequency 
of STI testing, are needed.
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In the United States, bacterial sexually transmitted infections (STI), including gonorrhea, 
chlamydia and syphilis, are highly prevalent among men who have sex with men (MSM). 
Among MSM attending sexually transmitted disease (STD) clinics, the prevalence of 
infection with rectal and pharyngeal N. gonorrhoeae and of rectal C. trachomatis is as high 
as 10.2%, 9.2% and 14.1%, respectively,1–5 and asymptomatic syphilis occurs in 4.3%.6 
Moreover, HIV-infected MSM are disproportionately affected by bacterial STI compared to 
their HIV-uninfected counterparts.7 In HIV primary care clinics, approximately 15% of 
MSM are diagnosed with an STI at baseline,8–10 and between 12.5% and 18% are diagnosed 
with an incident STI within the next year.8,9 STIs increase the risk of transmission of HIV,11 
yet the majority of bacterial STIs are asymptomatic.1,12 Testing and treating STIs may help 
reduce the risk of HIV transmission, particularly in high-risk populations with a high 
prevalence of STI.13,14
The U.S. Centers for Disease Control and Prevention (CDC) recommends that all MSM 
undergo routine STI screening at all exposed sites (urethra, pharynx, and/or rectum) at least 
annually.15 MSM considered at highest risk (those reporting more than 10 sexual partners in 
the past year, a history of a bacterial STI in the past year, use of amphetamines or poppers, 
or recent unprotected anal intercourse) should be screened as frequently as every three 
months. Despite these guidelines, HIV-infected MSM engaged in primary care do not 
routinely undergo recommended STI screenings.16,17 In a study of 8 large HIV clinics 
between 2004 and 2006, STI screening rates varied significantly by clinic, infection and 
anatomic site. Overall, syphilis screening occurred most frequently (66% – 76% of 1,334 
HIV-infected MSM screened at least once annually) whereas rectal chlamydia screening the 
least (2.3% – 4.3% screened at least once annually). In general, gonorrhea and chlamydia 
screening, particularly at extra-genital (i.e. pharyngeal and rectal) sites occurred 
infrequently.18
Given these data, we undertook an initiative to increase bacterial STI screening among HIV-
infected MSM engaged in HIV primary care. As part of this initiative we sought to 1) 
quantify baseline STI testing rates at the largest HIV care clinic in the Pacific Northwest 
U.S., and 2) identify barriers to STI screening as described by patients attending this clinic, 
and by these patients’ primary care providers.
METHODS
In 2012, in response to a CDC-initiated effort to enhance technical assistance to clinics 
providing HIV care, the University of Washington (UW) Sexually Transmitted Disease 
Prevention Training Center (PTC) developed a strategic plan to assess and enhance STI 
screening among HIV-infected persons seen at the clinic which serves the majority of such 
persons in Seattle and King County, Washington. The UW PTC is one of eight regional 
CDC PTCs that aim to educate and train clinicians in HIV/STI. As part of our strategic plan, 
we outlined a stepwise approach to increase STI testing: 1) determine a baseline estimate of 
current STI testing frequency; 2) understand why STI testing was not occurring routinely; 
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and 3) develop an intervention to increase screening. Because this project was designed as a 
clinical quality improvement project, human subjects approval was not required.
The Harborview Madison Clinic is the largest HIV primary care clinic in the Pacific 
Northwest region of the United States. Located in Seattle, King County, Washington, it is 
part of the county hospital, Harborview Medical Center, and staffed by University of 
Washington physicians. In addition to primary care services, Madison Clinic offers 
specialized pharmacy services, case management, psychiatric and psychological services, 
neurology, dermatology, oncology and acupuncture. In 2012, there were 2,570 HIV-infected 
patients engaged in primary care services at Madison Clinic; 81% of those were men and 
66% (n=1,374) of these men were identified by their primary care provider as MSM. We 
chose this HIV primary care site for this effort, reasoning that we could reach the largest 
local patient population at risk for STI, and potentially impact rates of STI screening. 
Additionally, the close alliance between the UW PTC faculty and the Madison Clinic helped 
facilitate the project.
In order to quantify baseline STI testing frequency in this patient population, we extracted 
testing data from the clinic’s electronic medical record’s laboratory data in aggregate, 
evaluating all MSM engaged in care. The designation of MSM was determined through 
provider documentation, and engagement in care was defined as attending at least two clinic 
visits in an 18-month period (March 2011 – September 2012). We chose to quantify testing 
frequencies because we did not have information on symptom status, and were unable to 
assess screening rates. We calculated testing frequencies for each bacterial STI and 
corresponding anatomic site as the number of MSM who received at least one test divided 
by all MSM engaged in care, as follows:
Syphilis testing throughout the study period was accomplished either with an EIA or a RPR. 
Nucleic acid amplification test (NAAT), using the Aptima Combo 2 (GenProbe, San Diego, 
CA) was the only testing modality for urine-based gonorrhea and chlamydia testing 
throughout the time period. NAAT, also with the Aptima Combo 2, was introduced for 
extra-genital (i.e. pharyngeal and rectal) gonorrhea and chlamydia testing in September of 
2011. Prior to that time, the clinic relied on culture for pharyngeal and rectal gonorrhea and 
chlamydia testing. Thus, we considered either culture or NAAT of pharyngeal and rectal 
specimens in our analysis.
In order to evaluate patient-related barriers to STI testing in HIV primary care, we created a 
short, anonymous paper-based survey which was offered to all men in the clinic waiting 
room during check-in over a three-week period in May 2012. We employed a rapid 
assessment survey style, using 11 multiple choice questions and a free-response section. The 
survey focused on assessing sexual risk behaviors, most recent STI testing and source of 
care, and reasons for not seeking STI care in the primary care setting.
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We evaluated provider-related barriers to STI testing in HIV primary care using an 
anonymous online-survey which was sent via email to all clinic providers in June 2012. The 
33 providers invited to participate were all HIV primary care providers in Madison Clinic 
who care for a panel of HIV-infected persons. We aimed to assess knowledge-related 
barriers with both directed multiple choice questions as well as clinical scenarios. We also 
evaluated provider perspective for both patient and provider-related barriers to STI testing.
RESULTS
Baseline Testing Frequencies
Between March 2011 and September 2012, 1,456 MSM attended at least 2 clinic visits. In 
that time, 1,048 (72%) men had at least one syphilis serology; 586 (40%) provided a urine 
sample for gonorrhea and chlamydia testing; 466 (32%) had oropharyngeal testing for N. 
gonorrhoeae (culture or NAAT), and 422 (29%) underwent rectal swab for gonorrhea and/or 
chlamydia testing.
Patient-Related Barriers to STI Testing
Demographics and Risk Behaviors—We received 110 surveys completed by HIV-
infected MSM, approximately 7.6% of all MSM engaged in care. Most (69%) of the men 
reported being sexually active in the prior two months with a median of 1 sexual partner 
(range 1–20). The majority reported participating in both insertive (68%) and receptive 
(69%) anal intercourse, as well as performing (79%) and receiving (75%) fellatio; 57% of 
MSM reported participating in all behaviors (Figure 1). Patients reported high-risk sexual 
behaviors including using, or their sexual partners using, amphetamines or other injection 
drugs (16.4%) or having had a bacterial STI (25.5%) in the past 12 months.
Patient Self-reported STI Testing History—Patients reported their last STI screening 
as less than three months ago (44%), less than 6 months ago (20%), within the last 12 
months (16%) or more than one year ago (19%). Over 83% reported being screened by a 
blood test, 56% with a urine test, 50% at the throat and 46% at the rectum. Among MSM 
who reported performing oral sex (n=87), 58% said they were screened at the throat at their 
last STI testing visit, and among the MSM who reported receptive anal sex (n=76), 53% said 
their rectum was tested at their last STI testing visit.
Usual place for STI testing—When asked where they usually go for STI testing, the 
majority of respondents reported Madison Clinic (i.e. their HIV primary care clinic) (72%). 
However, a substantial minority (28%) indicated that they attended the local STD clinic, 
while 3% stated they went to a local outreach site. Some (6.4%) reported that they did not 
routinely test for STI. The men who did not test at the HIV care clinic (n=31) were asked 
why they chose to seek STI care outside of their primary care clinic. The respondents 
wanted “easier” testing (42%), preferred anonymity (21%), wanted more frequent testing 
(16%), said they did not “need” the HIV care clinic (13%), forgot (5%), cited cost or 
convenience (5%), and reported not needing STI testing due to abstinence (5%) (answers not 
mutually exclusive) (Figure 2).
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Provider-related Barriers to STI Testing
Twenty-eight (85%) of the clinic’s 33 care providers responded to the electronic survey. 
Respondents varied by level of training and consisted of ARNPs (n=1), medical students 
(n=1), residents (n=2), fellows (n=1), and attending physicians (n=23).
Knowledge-related Barriers—Some providers reported difficulties with both process 
and content knowledge: 25% were unaware of the availability of NAAT for extra-genital 
gonorrhea and chlamydia testing; 32% felt unsure about the current CDC STI testing 
guidelines; and 25% incorrectly identified the CDC-recommended two-drug therapy for 
pharyngeal gonorrhea.
Clinical Barriers—When asked about challenges related to complying with CDC 
guidelines for STI testing, providers responded that they lacked time (68%), patients seemed 
reluctant (39%), the provider was uncomfortable with discussing sexual practices and doing 
a genital exam (21%), they were afraid to appear judgmental (25%), and they lacked staff 
support and/or an interpreter (7%) (Figure 3). Providers reported their perception of why 
patients refused STI testing as patient reported not being “prepared” (55%), seeking testing 
elsewhere (i.e. the local STD Clinic) (82%), not believing they were at risk (64%), not 
having time (23%), or preferring a same-sex provider (27%) (responses not mutually 
exclusive).
DISCUSSION
At the largest HIV care clinic in the Pacific Northwest U.S., we found that the rate of routine 
testing for bacterial STI among MSM was low. HIV-infected MSM engaged in care reported 
participating in high-risk sexual behaviors, believed that they were screening regularly, and 
for the most part sought STI testing at the HIV care clinic. However, nearly one-third sought 
care elsewhere because they wanted easier, more frequent testing, and some preferred 
anonymity. Equally important, our results indicate that many primary care providers in this 
setting would clearly benefit from enhanced STI and sexual health knowledge, as well as 
comfort with addressing sexual health. Moreover, most providers cited operational barriers 
to increased STI testing.
Our findings are similar to those of other studies that have shown that engagement in 
primary care does not decrease risk-taking behaviors. The patients who completed our 
survey, although engaged in HIV primary care, continue to participate in high-risk sexual 
behaviors, as evidenced by drug use (16%), self-reported bacterial STIs (25%) and reports of 
both insertive (68%) and receptive anal sex (69%). The participation in risky sexual 
behaviors among HIV-infected MSM engaged in care has been documented previously in a 
multi-site trial,8 suggesting this issue is not unique to the Pacific Northwest region. 
Evidence of these continued high-risk behaviors mandates an ongoing need for sexual risk 
assessment, risk reduction counseling, and STI testing and treatment in HIV care settings. 
Despite these findings, we found low levels of routine STI testing, similar to other published 
studies. A large medical record review of 8 HIV care clinics found that at least once annual 
extra-genital gonorrhea and chlamydia screening ranged from 2.3 – 18.3%.18 At the Johns 
Hopkins Hospital HIV Clinic between 1999 – 2007, only 39% of HIV-infected MSM were 
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ever tested for gonorrhea and chlamydia, and only 10% of the enrollment visit STI testing 
included an extra-genital site.16 A 2008 – 2010 survey by the Medical Monitoring Project 
(MMP), which aims to generate a nationally representative sample of HIV-infected adults, 
estimated that among all MSM engaged in care, 54% were tested for syphilis, and 20% for 
gonorrhea and chlamydia in the last 12 months.17 Our baseline testing frequencies (29–32%) 
exceeded these numbers, but also occurred in the era of NAAT testing for extra-genital 
gonorrhea and chlamydia, an approach that is technically simpler than culture and 
considerably more sensitive. Interestingly, the frequency of syphilis testing (72%) in our 
analysis nearly matches the rate of syphilis testing (66–76%) in the eight-clinic review.18 
The discrepancy between the frequency of extra-genital and syphilis testing is most likely 
related to the fact that syphilis testing relies on phlebotomy. Because HIV-infected patients 
routinely undergo blood draws to monitor HIV plasma viral loads and for anti-retroviral 
related toxicity, adding another test to the same sample is relatively simple. However, 
obtaining swabs of two anatomic sites – one of which necessitates the patient undressing – 
introduces additional barriers to testing.
Very few studies have examined patient-related barriers to STI testing in HIV primary care. 
One qualitative study that included both HIV-infected and -uninfected subjects asked about 
the features of an ideal STI/HIV testing environment. Similar to our findings, men in the that 
study wanted a testing environment that was “accessible… with walk-in hours”, offered 
anonymous testing, and was overall “community-based, friendly… and normalized… 
STD/HIV testing.”19 The patients who responded to our survey also indicated that they went 
outside of their primary care clinic for “easier”, anonymous, more frequent and convenient 
testing. Although “easier” was not defined in our survey, interpreted in the context of 
accessibility, it might also mean not needing an appointment, and being able to walk-in. 
However, “easier” may also refer to interactions with providers if related to the high 
proportion who preferred anonymity. Although anonymity is not possible in a primary care 
clinic, there may be ways to separate sexual health assessments and STI testing from the 
primary provider-patient relationship, allowing testing to occur within the medical home, yet 
not cause discomfort for either party. Additionally, as we move to less frequent routine HIV 
care appointment (i.e. every 6 months, as compared to every three months), high-risk MSM 
will need testing more frequently than can be offered during routine care. The availability of 
walk-in testing in between primary care visits may address this structural barrier.
Importantly, we found that a substantial proportion of health care providers lacked 
knowledge crucial for STI testing and treatment in terms of when and how to test, as well as 
how to treat a positive result. Ideally, this deficiency can be corrected through provider 
education. Similar to other studies, providers reported a lack of time and discomfort with 
taking a sexual history and performing genital exams as major barriers to STI testing. These 
have been consistent complaints from providers across the United States, both in studies 
specific to STI testing in HIV primary care20 and those on sexual behavior assessments in 
HIV/STD care settings.21 Those studies also identified competing medical priorities and 
cultural/language issues as a significant barriers to preventive services; our study did not 
directly assess those obstacles.
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Our assessment has several limitations. Our testing coverage data is extracted in aggregate 
from the medical record. As such, it does not allow us to determine whether patients were 
asymptomatic at the time of testing (i.e. screening), their individualized risk status, anatomic 
sites of exposure, or frequency of testing. Thus, these testing rates may be either an under- 
or over-estimate of appropriate testing practice. Second, we used convenience sampling to 
recruit MSM to complete the patient survey; thus, these men may not be representative of 
the wider MSM clinic population at this clinic or in other parts of the United States. 
However, the self-reported history of recent bacterial STI (25%) is similar to directly 
assessed reports from other HIV care clinics.8 Additionally, we limited the questions to 
comply with a rapid assessment format because of the clinical setting of the survey and 
associated time constraints. Therefore, we were unable to assess STI testing knowledge as a 
potential barrier to more frequent testing. However, nearly half of the participants had tested 
in the last three months and over 60% within the last 6 months suggesting that on some level 
these men know regular STI testing is important. Finally, we are unable to correlate stage of 
training with the STI knowledge and comfort with sexual health evaluations as the provider 
survey was anonymous. However, even if all of the trainees reported deficits in knowledge 
and comfort questions, there were still several attending physicians who were unsure or 
uncomfortable as well.
Understanding the patient- and provider-related barriers to STI testing in HIV primary care 
is the first step to being able to implement an efficacious STI testing program. While 
increasing provider knowledge and comfort-level with sexual health needs of their HIV-
infected patients must remain a priority, our data suggest that a convenient and “easy” STI 
testing program that relieves providers of the time burden while facilitating the assessment 
of sexual risk is needed. One such option is an STI self-testing program that allows for 
patients to self-assess risk, obtain their own swabs and utilize the laboratory for syphilis 
testing, virtually eliminating the need for the provider. In the context of an HIV care clinic, 
this program could function either with the provider recommending testing, or the patient 
seeking STI testing on his own, overcoming both patient and provider-related barriers. 
Current approaches to provide this option are in process.
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The frequency of STI screening of MSM in HIV care remains low. Most patients seek 
STI testing through primary care, but some want easier, frequent, anonymous testing. 
Providers lack knowledge, comfort and time.
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Reported sexual activities among HIV-infected MSM in an HIV Care Clinic (N=110)
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Reasons why HIV-infected MSM seek STI testing services outside of HIV primary care 
clinic
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HIV care providers’ reported barriers to STI testing in HIV primary care
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